Vascular Endothelial Growth Factor VEGF Inhibitors Market Insights Video

According to Cognitive Market Research, the global Vascular Endothelial Growth Factor VEGF Inhibitors market size is USD 19542.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 11.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 7816.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 5862.66 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 4494.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 977.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 390.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031.
• The VEGF-A Inhibitor held the highest Vascular Endothelial Growth Factor VEGF Inhibitors market revenue share in 2024.